Northern Trust Corp Fulcrum Therapeutics, Inc. Transaction History

Northern Trust Corp

$600 Billion
Q3 2024

A detailed history of Northern Trust Corp transactions in Fulcrum Therapeutics, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 567,743 shares of FULC stock, worth $2.47 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

567,743

Previous 166,894 240.18%

Holding current value

$2.47 Million

Previous $1.03 Million 95.94%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$3.18 - $9.74 $1.27 Million - $3.9 Million	400,849 Added 240.18%	567,743 $2.03 Million
Q2 2024 Aug 14, 2024	BUY	$5.98 - $9.31 $182,156 - $283,591	30,461 Added 22.33%	166,894 $1.03 Million
Q1 2024 May 14, 2024	SELL	$6.7 - $12.0 $57,164 - $102,384	-8,532 Reduced 5.89%	136,433 $1.29 Million
Q4 2023 Feb 13, 2024	BUY	$3.18 - $6.86 $6,309 - $13,610	1,984 Added 1.39%	144,965 $978,000
Q3 2023 Nov 13, 2023	SELL	$3.25 - $6.08 $1,449 - $2,711	-446 Reduced 0.31%	142,981 $634,000
Q2 2023 Aug 11, 2023	SELL	$2.26 - $3.8 $697,266 - $1.17 Million	-308,525 Reduced 68.26%	143,427 $473,000
Q1 2023 May 15, 2023	BUY	$2.83 - $13.99 $173,977 - $860,049	61,476 Added 15.74%	451,952 $1.29 Million
Q4 2022 Feb 13, 2023	BUY	$5.01 - $8.35 $396,706 - $661,178	79,183 Added 25.44%	390,476 $2.84 Million
Q3 2022 Nov 14, 2022	BUY	$4.92 - $9.1 $14,755 - $27,290	2,999 Added 0.97%	311,293 $2.52 Million
Q2 2022 Aug 12, 2022	BUY	$4.2 - $24.0 $215,745 - $1.23 Million	51,368 Added 19.99%	308,294 $1.51 Million
Q1 2022 May 13, 2022	SELL	$9.96 - $23.65 $61,224 - $145,376	-6,147 Reduced 2.34%	256,926 $6.08 Million
Q4 2021 Feb 08, 2022	BUY	$14.0 - $28.44 $72,814 - $147,916	5,201 Added 2.02%	263,073 $4.65 Million
Q3 2021 Nov 15, 2021	BUY	$7.28 - $30.97 $292,372 - $1.24 Million	40,161 Added 18.45%	257,872 $7.28 Million
Q2 2021 Aug 13, 2021	BUY	$8.09 - $12.0 $165,869 - $246,036	20,503 Added 10.4%	217,711 $2.28 Million
Q1 2021 May 12, 2021	BUY	$10.94 - $15.32 $78,757 - $110,288	7,199 Added 3.79%	197,208 $2.32 Million
Q4 2020 Feb 11, 2021	BUY	$7.84 - $13.4 $92,825 - $158,656	11,840 Added 6.65%	190,009 $2.23 Million
Q3 2020 Nov 16, 2020	BUY	$7.22 - $20.7 $77,225 - $221,407	10,696 Added 6.39%	178,169 $1.41 Million
Q2 2020 Aug 14, 2020	BUY	$9.11 - $22.06 $302,342 - $732,127	33,188 Added 24.71%	167,473 $3.06 Million
Q1 2020 May 14, 2020	BUY	$9.49 - $21.26 $789,881 - $1.77 Million	83,233 Added 163.04%	134,285 $1.6 Million
Q4 2019 Feb 14, 2020	SELL	$4.46 - $18.14 $9,629 - $39,164	-2,159 Reduced 4.06%	51,052 $849,000
Q3 2019 Nov 13, 2019	BUY	$6.64 - $14.89 $353,321 - $792,311	53,211 New	53,211 $353,000

Others Institutions Holding FULC

# of Institutions

150

Shares Held

52.2M

Call Options Held

6.91M

Put Options Held

1.9M

View Full List

About Fulcrum Therapeutics, Inc.

Ticker FULC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,038,900
Market Cap $226M
Description
Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystro...

More about FULC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Fulcrum Therapeutics, Inc. Transaction History